DE69600011D1 - Verwendung von Derivaten des Melanocyte-stimulierenden Hormons vom Typ alpha zur Stimulierung des Haarwachstums - Google Patents

Verwendung von Derivaten des Melanocyte-stimulierenden Hormons vom Typ alpha zur Stimulierung des Haarwachstums

Info

Publication number
DE69600011D1
DE69600011D1 DE69600011T DE69600011T DE69600011D1 DE 69600011 D1 DE69600011 D1 DE 69600011D1 DE 69600011 T DE69600011 T DE 69600011T DE 69600011 T DE69600011 T DE 69600011T DE 69600011 D1 DE69600011 D1 DE 69600011D1
Authority
DE
Germany
Prior art keywords
melanocyte
derivatives
hair growth
stimulating hormone
alpha type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69600011T
Other languages
English (en)
Other versions
DE69600011T2 (de
Inventor
Yann Mahe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE69600011D1 publication Critical patent/DE69600011D1/de
Publication of DE69600011T2 publication Critical patent/DE69600011T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69600011T 1995-04-28 1996-03-27 Verwendung von Derivaten des Melanocyte-stimulierenden Hormons vom Typ alpha zur Stimulierung des Haarwachstums Expired - Fee Related DE69600011T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505158A FR2733421B1 (fr) 1995-04-28 1995-04-28 Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute

Publications (2)

Publication Number Publication Date
DE69600011D1 true DE69600011D1 (de) 1997-05-07
DE69600011T2 DE69600011T2 (de) 1997-07-03

Family

ID=9478562

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69600011T Expired - Fee Related DE69600011T2 (de) 1995-04-28 1996-03-27 Verwendung von Derivaten des Melanocyte-stimulierenden Hormons vom Typ alpha zur Stimulierung des Haarwachstums

Country Status (6)

Country Link
US (1) US5739111A (de)
EP (1) EP0759292B1 (de)
JP (1) JP2880125B2 (de)
DE (1) DE69600011T2 (de)
ES (1) ES2102921T3 (de)
FR (1) FR2733421B1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781157B1 (fr) * 1998-07-15 2000-08-25 Oreal Composition anti-inflammatoire
FR2784028B1 (fr) 1998-10-01 2003-02-07 Oreal Utilisation d'un peptide prevenant les reactions d'intolerance de la peau, notamment dans des compositions cosmetiques
US6159950A (en) * 1998-10-16 2000-12-12 Cornell Research Foundation, Inc. Method of modulating hair growth
US7402559B2 (en) * 1999-03-24 2008-07-22 Msh Pharma, Incorporated Composition and method of treatment for urogenital conditions
US6800291B1 (en) * 1999-03-24 2004-10-05 Zengen, Inc. Uro-genital condition treatment system
ATE375801T1 (de) * 1999-03-24 2007-11-15 Zengen Inc Antimikrobielle aminosäuresequenzen aus alpha- melanocyten-stimulierendem hormon
US6803044B1 (en) 1999-03-24 2004-10-12 Zengen, Inc. Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus
US6887846B2 (en) 1999-03-24 2005-05-03 Zengen, Inc. Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
US6780838B2 (en) * 2001-01-29 2004-08-24 Zengen, Inc. Compounds for treating fungal pathologies of the oral cavity
DE10106852A1 (de) 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
US6894028B2 (en) 2001-04-06 2005-05-17 Zengen, Inc. Use of KPV tripeptide for dermatological disorders
FR2826581B1 (fr) * 2001-06-29 2005-10-07 Oreal Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes
FR2826580B1 (fr) * 2001-06-29 2005-09-30 Oreal Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices
US20030108523A1 (en) * 2001-09-05 2003-06-12 Lipton James M. Cancer treatment system
US7107316B2 (en) * 2001-09-20 2006-09-12 International Business Machines Corporation Controlling throughput of message requests in a messaging system
US7115574B2 (en) 2001-12-10 2006-10-03 Zengen, Inc. System and method for support legacy operating system booting in a legacy-free system
US6939846B2 (en) 2001-12-17 2005-09-06 Zengen, Inc. Use of a polypeptide for treatment of pruritis in animals
FR2857667B1 (fr) 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie
FR2857597B1 (fr) 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
FR2863484B1 (fr) * 2003-12-11 2007-04-13 Oreal Utilisation de composes capables d'agir sur la voie metabolique controlee par la dopachrome tautomerase trp-2 comme agent protecteur des melanocytes du follicule pileux et applications
JP4654418B2 (ja) * 2004-03-31 2011-03-23 独立行政法人産業技術総合研究所 上皮系細胞増殖促進剤
US7223562B2 (en) * 2004-03-31 2007-05-29 New York University Compositions for controlling hair growth
FR2882256B1 (fr) * 2005-02-18 2007-05-25 Centre Nat Rech Scient Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent pour ralentir la chute des cheveux et/ou stimuler leur croissance
WO2006106528A1 (en) * 2005-04-07 2006-10-12 Dabur Pharma Limited Novel peptides useful for treatment of alopecia
US8288366B2 (en) 2006-06-20 2012-10-16 Chochinov Ronald H Formulation for hair growth
AU2008327932B2 (en) * 2007-11-19 2012-05-31 Universitaetsklinikum Muenster Compositions for reducing oxidative stress and uses thereof
US9156881B2 (en) 2011-09-23 2015-10-13 Westfaelische Wilhelms-Universitaet Muenster Tripeptide KDPT for antiapoptotic treatment
JP2013163661A (ja) * 2012-02-10 2013-08-22 Fuji Sangyo Kk 育毛剤
US9827181B2 (en) 2013-06-05 2017-11-28 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
US9402876B2 (en) 2013-11-27 2016-08-02 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US5028592A (en) * 1986-08-08 1991-07-02 Lipton James M Antipyretic and anti-inflammatory peptides
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
KR900005903B1 (ko) * 1986-02-03 1990-08-16 유니버시티 페이턴츠 아이엔씨 알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물
DE3603601C3 (de) * 1986-02-06 1999-12-23 Jutta Mai Verwendung eines Bockshornkleesamenextraktes
CA1323839C (en) * 1987-05-11 1993-11-02 Loren Ralph Pickart Methods for stimulating hair growth
DE3867710D1 (de) * 1987-06-01 1992-02-27 Keikichi Sugiyama Zusammensetzung zur anwendung auf haare und kopfhaut.
JPH01207225A (ja) * 1988-02-12 1989-08-21 Taiyo Kagaku Co Ltd 毛髪化粧料
JPH0543424A (ja) * 1991-08-14 1993-02-23 Sansho Seiyaku Co Ltd 毛髪用外用剤
JPH05213720A (ja) * 1992-02-05 1993-08-24 Sansho Seiyaku Co Ltd 毛髪用外用剤
JPH05213721A (ja) * 1992-02-05 1993-08-24 Sansho Seiyaku Co Ltd 毛髪用外用剤
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes

Also Published As

Publication number Publication date
JPH08301729A (ja) 1996-11-19
DE69600011T2 (de) 1997-07-03
JP2880125B2 (ja) 1999-04-05
EP0759292A1 (de) 1997-02-26
FR2733421A1 (fr) 1996-10-31
US5739111A (en) 1998-04-14
ES2102921T3 (es) 1997-08-01
FR2733421B1 (fr) 1997-06-06
EP0759292B1 (de) 1997-03-26

Similar Documents

Publication Publication Date Title
DE69600011D1 (de) Verwendung von Derivaten des Melanocyte-stimulierenden Hormons vom Typ alpha zur Stimulierung des Haarwachstums
DE69622154D1 (de) Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses
ATE227587T1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
ATE264916T1 (de) Dns-konstrukten zur aktivierung und veränderung der expression von endogenen genen
DE69532167D1 (de) Inhibitierung des haarwuchses
DE69306215D1 (de) Klare, auf dem Haar verbleibende Zusammensetzung zur Pflege der Haare und Verfahren zur Verwendung
KR950700990A (ko) 신규의 분비단백질 에프-스폰딘의 클로닝, 발현 및 용도
DE69325451D1 (de) Verwendung von pyruvamid und ausgewählten pyruvyl-aminosäuren
DE69614255D1 (de) Zusammensetzung zur haarpflege
ATE217754T1 (de) Verwendung von aerogelen in der landwirtschaft
DE69101922D1 (de) Verwendung von pyrimidin-3-oxydderivaten zur verhütung von haarausfall und deren anwendung in topischen zusammensetzungen.
DE69421778D1 (de) Verwendung von wirksamen Mengen von aktiven Stoffen zur Behandlung von Mischhaut
DE69617652D1 (de) Verminderung des haarwuchses
DE69227392D1 (de) Serumfreies Medium zur Züchtung von Tierzellen
DE3867710D1 (de) Zusammensetzung zur anwendung auf haare und kopfhaut.
ATE216979T1 (de) Anwendung von amides zur kontrolle des biobewuchses
ATE292975T1 (de) Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
DE69515070D1 (de) Zusammensetzung auf der Basis von alpha-Pyronen zur Induzierung und Stimulierung des Haarwachstums und/oder zur Verlangsamung des Haarausfalls und ihre Verwendung
ATE305477T1 (de) Behandlung von insulinresistenz mit wachstumhormonfördernden stoffen
DE69734296D1 (de) Neue dikaffeoylchinasäurederivate und deren verwendung zur behandlung von hepatitis b
DE69123178D1 (de) Verwendung von Uridin zur pharmakologischen Behandlung der peripheren Komplikationen bei Diabetes
DE69534371D1 (de) Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
ATE182586T1 (de) Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee